Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 25, 1998

View Archived Issues

Lilly To Pay Xenova $35M For Heart Attack Drug

Gene Found That Keeps Female Embryos Female

Genset's Revenues Double; But R&D Spending Widens '97 Loss

Canadian Biotech Groups Merge To Form National Body

Appligène Oncor Reports Disappointing '97 Results

Foiled By Nonviral Vectors, Therexsys Shifts Gene Therapy

Cerep's IPO On Nouveau Marché Raises FFr67.5M

Germany Backs China's Biotech International Exhibition

EU Advisory Panel On Ethics Formed With Lenoir As Chairman

Amrad Acquires Diagnostic Firm For A$50M In Cash, Stock

HIV Drug Developer Frustrated; Pursuing Studies In China

Peptech Making Changes; Returning To Australia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...